Azilsartan (Edarbi): a new ARB for treating hypertension
Prescriber(2013)
摘要
Azilsartan medoxomil (Edarbi) is a new angiotensin-II receptor blocker for use in the treatment of hypertension. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Professor Gordon McInnes discusses its place in treatment.
更多查看译文
关键词
hypertension,new edarbi
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络